Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.55
0.11 (7.64%)
At close: Aug 18, 2025, 3:59 PM
1.51
-2.58%
After-hours: Aug 18, 2025, 04:43 PM EDT
Galmed Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.35M | -7.52M | -6.32M | -5.88M | -6.36M | -6.91M | -7.54M | -11.41M | -13.55M | -17.87M | -22.68M | -25.04M | -29.7M | -32.47M | -35.29M | -34.48M | -31.61M |
Depreciation & Amortization | 74K | 83K | 89K | 97K | 32K | 31K | 34K | 34K | 34K | 35K | 36K | 39K | 40K | 42K | 43K | 41K | 40K |
Stock-Based Compensation | 479K | 531K | 610K | 704K | 748K | 892K | 879K | 864K | 1.14M | 1.3M | 1.48M | 1.85M | 1.87M | 1.89M | 2.11M | 1.91M | 2.02M |
Other Working Capital | 124K | 42K | 640K | -542K | -183K | 523K | 598K | 265K | -259K | -422K | -357K | -1.11M | -528K | -275K | -804K | 774K | 595K |
Other Non-Cash Items | 1.72M | 2.19M | -83K | -129K | 39K | -537K | 267K | 315K | 185K | 485K | 251K | 214K | 183K | 13K | -10K | -516K | -613K |
Deferred Income Tax | n/a | n/a | 488K | 574K | 257K | 257K | -231K | -317K | n/a | n/a | 1K | -23K | 48K | 84K | 132K | 156K | 111K |
Change in Working Capital | -144K | -721K | 852K | -844K | -550K | 132K | -2.68M | 316K | -2.55M | -2.45M | -559K | -4.37M | -1.5M | -2.45M | -722K | 2.53M | 1.07M |
Operating Cash Flow | -5.22M | -5.88M | -4.81M | -5.92M | -6.27M | -6.14M | -9.26M | -10.2M | -14.74M | -18.5M | -21.47M | -27.34M | -29.06M | -32.89M | -33.74M | -30.36M | -28.98M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -4K | -4K | -4K | -6K | -10K | -11K | -21K | -47K | -45K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -6.12M | -6.37M | -4.24M | -7.27M | -9.86M | -9.73M | -12.44M | -7.84M | -5.02M | -3.87M | -1.75M | -5.74M | -3.56M | -13.57M | 2.54M | -7.47M | -29.23M |
Sales Maturities Of Investments | 4.6M | 5.5M | 5.55M | 4.44M | 7.84M | 8.63M | 30.29M | 18.5M | 17.63M | 21.44M | 7.89M | 27.14M | 22.99M | 25.04M | 696K | 22.17M | 40.25M |
Other Investing Acitivies | -250K | 182K | 3.83M | 432K | -1.07M | -1.5M | -20.74M | -1.5M | 5.5K | 10.46K | 15.85M | 14.02K | 12.04K | 4.09K | 3.23K | 14.7K | 11.02K |
Investing Cash Flow | -1.77M | -1.11M | 4.72M | 568K | -119K | 800K | 500K | 9.16M | 12.61M | 17.56M | 21.97M | 21.4M | 19.41M | 11.46M | 3.21M | 14.66M | 10.98M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.94M | 3.94M | 8.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 10.3M | 8.79M | 8.34M | 6.18M | 6.18M | 6.18M | 6.18M | 70K | 70K | 70K | 70K | n/a | n/a | 17.37M | 17.37M | 18.07M | 18.07M |
Net Cash Flow | 3.31M | 1.79M | 8.25M | 831K | -206K | 848K | -2.58M | -970K | -2.07M | -868K | 572K | -5.94M | -9.64M | -4.06M | -13.16M | 2.37M | 69K |
Free Cash Flow | -5.22M | -5.88M | -4.81M | -5.92M | -6.27M | -6.14M | -9.26M | -10.2M | -14.75M | -18.5M | -21.47M | -27.34M | -29.07M | -32.9M | -33.76M | -30.41M | -29.03M |